These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

960 related articles for article (PubMed ID: 33981057)

  • 1. How COVID broke the evidence pipeline.
    Pearson H
    Nature; 2021 May; 593(7858):182-185. PubMed ID: 33981057
    [No Abstract]   [Full Text] [Related]  

  • 2. [From empiricism to scientific evidence in antiviral treatment in severe cases of coronavirus infection in times of epidemic].
    Estella Á; Garnacho-Montero J
    Med Intensiva (Engl Ed); 2020 Nov; 44(8):509-512. PubMed ID: 32423569
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19).
    Khunti S; Khunti N; Seidu S; Khunti K
    Diabetes Obes Metab; 2020 Oct; 22(10):1942-1945. PubMed ID: 32319200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Of chloroquine and COVID-19.
    Touret F; de Lamballerie X
    Antiviral Res; 2020 May; 177():104762. PubMed ID: 32147496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety fears over drug hyped to treat the coronavirus spark global confusion.
    Ledford H
    Nature; 2020 Jun; 582(7810):18-19. PubMed ID: 32488162
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancing COVID-19 decision making by creating an assurance case for epidemiological models.
    Habli I; Alexander R; Hawkins R; Sujan M; McDermid J; Picardi C; Lawton T
    BMJ Health Care Inform; 2020 Sep; 27(3):. PubMed ID: 32900694
    [No Abstract]   [Full Text] [Related]  

  • 7. Access to data from clinical trials in the COVID-19 crisis: open, flexible, and time-sensitive.
    Ewers M; Ioannidis JPA; Plesnila N
    J Clin Epidemiol; 2021 Feb; 130():143-146. PubMed ID: 33068714
    [No Abstract]   [Full Text] [Related]  

  • 8. Science and Evidence-Based Review and Approval of COVID-19 Vaccines: A Statement of Support for the US FDA.
    Pai SM; Othman AA; Rusch L; Masters JC; Greene D; Rogge M; Gries JM; Clementi W; Kumar P; Younis I; Salem AH; Gaynes BI; Pastino G; Derendorf H;
    J Clin Pharmacol; 2021 Mar; 61(3):277-279. PubMed ID: 33274473
    [No Abstract]   [Full Text] [Related]  

  • 9. A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.
    Mitjà O; Corbacho-Monné M; Ubals M; Alemany A; Suñer C; Tebé C; Tobias A; Peñafiel J; Ballana E; Pérez CA; Admella P; Riera-Martí N; Laporte P; Mitjà J; Clua M; Bertran L; Sarquella M; Gavilán S; Ara J; Argimon JM; Cuatrecasas G; Cañadas P; Elizalde-Torrent A; Fabregat R; Farré M; Forcada A; Flores-Mateo G; López C; Muntada E; Nadal N; Narejos S; Nieto A; Prat N; Puig J; Quiñones C; Ramírez-Viaplana F; Reyes-Urueña J; Riveira-Muñoz E; Ruiz L; Sanz S; Sentís A; Sierra A; Velasco C; Vivanco-Hidalgo RM; Zamora J; Casabona J; Vall-Mayans M; González-Beiras C; Clotet B;
    N Engl J Med; 2021 Feb; 384(5):417-427. PubMed ID: 33289973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials.gov.
    Pundi K; Perino AC; Harrington RA; Krumholz HM; Turakhia MP
    JAMA Intern Med; 2020 Oct; 180(10):1398-1400. PubMed ID: 32730617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The coronavirus outbreak could make it quicker and easier to trial drugs.
    Ledford H
    Nature; 2020 Jun; 582(7811):172. PubMed ID: 32504019
    [No Abstract]   [Full Text] [Related]  

  • 12. Bringing evidence from press release to the clinic in the era of COVID-19.
    McMahon JH; Lydeamore MJ; Stewardson AJ
    J Antimicrob Chemother; 2021 Feb; 76(3):547-549. PubMed ID: 33331867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Make journals report clinical trials properly.
    Goldacre B
    Nature; 2016 Feb; 530(7588):7. PubMed ID: 26842021
    [No Abstract]   [Full Text] [Related]  

  • 14. Precision Medicine Versus Evidence-Based Medicine: Individual Treatment Effect Versus Average Treatment Effect.
    Blackstone EH
    Circulation; 2019 Oct; 140(15):1236-1238. PubMed ID: 31589490
    [No Abstract]   [Full Text] [Related]  

  • 15. The COVID-19 pandemic and a reflection on the conduct of clinical trials in times of war.
    Pacheco RL; Cabrera Martimbianco AL; Riera R
    J Clin Epidemiol; 2021 Apr; 132():131-132. PubMed ID: 33301908
    [No Abstract]   [Full Text] [Related]  

  • 16. Towards evidence based medicine for paediatricians.
    Phillips B
    Arch Dis Child; 2016 Jun; 101(6):586. PubMed ID: 27207846
    [No Abstract]   [Full Text] [Related]  

  • 17. [In search of lost evidence. Proposals for increasing the transparency of clinical trials].
    Urrutia G; Bonfill X; Martí J
    Med Clin (Barc); 1999; 112 Suppl 1():21-7. PubMed ID: 10618796
    [No Abstract]   [Full Text] [Related]  

  • 18. What is right and what is wrong about evidence-based medicine?
    Julian DG
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S2-5. PubMed ID: 12950509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
    Nina PB; Dash AP
    Indian J Public Health; 2020 Jun; 64(Supplement):S125-S127. PubMed ID: 32496241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the COVILUS score to diagnose COVID-19 in an emergency room cohort.
    Bar S; Levivier C; Dupont H; Gosset P
    Anaesthesia; 2021 Aug; 76(8):1134-1135. PubMed ID: 33621362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 48.